<DOC>
	<DOCNO>NCT02624401</DOCNO>
	<brief_summary>Positron Emission Tomography ( PET ) , Magnetic Resonance Imaging ( MRI ) electroencephalography ( EEG ) study carry reveal neural correlate consciousness . Consciousness subject manipulate anesthetic agent dexmedetomidine , propofol , S-ketamine sevoflurane . One-hundred-and-sixty ( 160 ) healthy male subject recruit receive EC50 concentration anesthetic ( 40 dexmedetomidine , 40 propofol , 20 S-ketamine , 40 sevoflurane ) placebo ( 20 ) image cerebral metabolic rate glucose ( CMRglu ) . Also genetic , immunological metabolomics sample take analysed find possible genetic factor explain variability drug response find chemical fingerprint acute drug effect .</brief_summary>
	<brief_title>The Neural Mechanisms Anesthesia Human Consciousness ( Part 6 )</brief_title>
	<detailed_description>The explanation consciousness pose one greatest challenge science philosophy 21st century . It remain unclear consciousness emerge brain activity . Positron Emission Tomography ( PET ) , Magnetic Resonance Imaging ( MRI ) electroencephalography ( EEG ) study carry reveal neural correlate consciousness . Consciousness subject manipulate anesthetic agent dexmedetomidine act Î±2-agonism , propofol sevoflurane mainly act enhancement gamma-aminobutyric acid ( GABA ) system , S-ketamine act N-methyl-D-aspartate ( NMDA ) receptor antagonism . One-hundred-and-sixty ( 160 ) healthy male subject recruit receive EC50 concentration either dexmedetomidine , propofol , S-ketamine sevoflurane , placebo image cerebral metabolic rate glucose ( CMRglu ) . 40 subject receive dexmedetomidine , 40 subject propofol , 20 subject S-ketamine , 40 subject sevoflurane 20 subject receive placebo . Also genetic , immunological metabolomics sample take analysed find possible genetic factor explain variability drug response find possible immunological chemical fingerprint acute drug effect .</detailed_description>
	<mesh_term>Unconsciousness</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<mesh_term>Sevoflurane</mesh_term>
	<criteria>1 . Male 2 . Age 1830 year 3 . Good general health i.e . American Society Anesthesiologists ( ASA ) physical status I 4 . Fluent Finnish language 5 . Right handedness 6 . Written inform consent 7 . Good sleep quality 1 . Chronic medication 2 . History alcohol and/or drug abuse 3 . Strong susceptibility allergic reaction 4 . Serious nausea connection previous anesthesia 5 . Strong susceptibility nausea 6 . Any use drug alcohol 48 hour precede anesthesia 7 . Use caffeine product 1012 hour prior study 8 . Smoking 9 . Clinically significant previous cardiac arrhythmia / cardiac conduction impairment 10 . Clinically significant abnormality prestudy laboratory test 11 . Positive result drug screen test 12 . Blood donation within 90 day prior study 13 . Participation medical study experimental drug device precede 60 day 14 . The study subject undergone prior PET SPECT study 15 . Any contraindication magnetic resonance imaging ( MRI ) 16 . Hearing impairment 17 . Detected unsuitability base MRI scan result available PET scan 18 . Sleep disorder severe sleep problem</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>